Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Direct | Direct |
| Fund house | Nippon India | Axis |
| NAV | ₹16.3729 | ₹10.7623 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 4.2 years | 2 months |
| Expense ratio | 0.5% | 1.9% |
| Stars | ★★★★★ | Not rated |
| Growth Score | 23.60 | — |
Returns
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| 1 month | +9.52% | +8.88% |
| 3 months | −0.46% | — |
| 6 months | +5.96% | — |
| YTD | +0.62% | — |
| 1 year | +0.65% | — |
| 3 years (CAGR) | +9.44% | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +12.60% | +9.97% |
Risk
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Volatility | 16.9% | — |
| Downside volatility | 12.4% | — |
| Sharpe | 0.17 | — |
| Sortino | 0.24 | — |
| Calmar | 0.38 | — |
| Return / risk | 0.56 | — |
| Deepest fall | −24.91% | −2.57% |
| Days to recover | — | 7 |
| Below its high | −13.38% | +0.00% |
Against benchmark
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Best 1-year | +59.15% | — |
| Middle 1-year | +4.23% | — |
| Worst 1-year | −16.81% | — |
| 1-year periods with a loss | 39.5% | — |
| Middle 3-year | +14.59% | — |
| Positive months | 61.1% | — |
| Best day | +3.62% | +1.52% |
| Worst day | −4.79% | −1.77% |
| Worst 5% day | −1.33% | −0.77% |
| Positive days | 53.4% | 65.6% |
| NAVs a year | 247 | 33 |
SIP of ₹10,000 a month
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | +2.78% | — |
| 1-year XIRR | +6.14% | — |
Holdings overlap i
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | — | 51% |
| Axis Nifty500 Low Volatility 50 Index Fund | 51% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund |
|---|---|---|
| NTPC Limited | 4.07% | 4.86% |
| Bharti Airtel Limited | 3.78% | 5.45% |
| Bajaj Auto Limited | 3.86% | 3.70% |
| Apollo Hospitals Enterprise Limited | 4.11% | 3.66% |
| Sun Pharmaceutical Industries Limited | 3.57% | 4.89% |
| State Bank of India | 3.18% | 5.06% |
| Coal India Limited | 2.82% | 2.91% |
| UltraTech Cement Limited | 2.80% | 4.08% |
| Asian Paints Limited | 2.65% | 2.91% |
| Torrent Pharmaceuticals Limited | 4.59% | 2.65% |
| Maruti Suzuki India Limited | 2.41% | 3.98% |
| The Federal Bank Limited | 3.83% | 2.23% |
| Marico Limited | 4.10% | 2.16% |
| Britannia Industries Limited | 2.82% | 2.11% |
| Eicher Motors Limited | 3.09% | 2.11% |
| TVS Motor Company Limited | 3.34% | 2.09% |
| Lupin Limited | 3.24% | 1.91% |
| Pidilite Industries Limited | 3.09% | 1.74% |
| Zydus Lifesciences Limited | 3.02% | 1.05% |
| Max Financial Services Limited | 1.93% | 0.77% |
Sectors and company size
| Nippon India Nifty Alpha Low Volatility 30 Index Fund | Axis Nifty500 Low Volatility 50 Index Fund | |
|---|---|---|
| Large companies | 83.9% | 83.1% |
| Mid companies | 16.1% | 18.4% |
| Small companies | — | 1.3% |
| Top 10 holdings | 39.6% | 46.9% |
| Largest sector | Pharmaceuticals & Biotechnology 14% | Pharmaceuticals & Biotechnology 20% |